Narcolepsy Symptoms Normalize With Novel Agent
A novel drug to supply the severe lack of brain orexin neuropeptides that…
Browsing Tag
narcolepsy
Once-Nightly Narcolepsy Drug Preferred by Patients Over Twice-Nightly Dose
INDIANAPOLIS -- Extended-release sodium oxybate (Lumryz) taken once before bedtime was preferred by patients with…
FDA Approves Lumryz for Narcolepsy
Lori Solomon
THURSDAY, May 4, 2023 (HealthDay News) -- The U.S. Food & Drug Administration has approved Lumryz for the treatment of cataplexy or…
Avadel Pharmaceuticals Announces Final FDA Approval of LUMRYZ™ (sodium oxybate) for…
<!-- Name:DistributionId Value:8829171 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Axsome Therapeutics to Present Five Abstracts Including New Data from the Positive…
<!-- Name:DistributionId Value:8812646 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Pitolisant Safe and Effective in Children With Narcolepsy
Pitolisant (Wakix) in children ages 6 years and up led to clinically meaningful improvements…
Family Builds Empire Off ‘Christian’ Insurance; Narcolepsy Drug Patent…
Welcome to the latest edition of Investigative Roundup, highlighting some of the best…
Avadel Presents New Real-World Data Describing Demographic Characteristics and…
- Results identify mood, sleep and pain disorders as the most common comorbidities in people living with narcolepsy - - Encore presentations at ANA 2022 reinforce positive data from…
Axsome Therapeutics Hosts Sunosi® Investor Update Virtual Event Today with Key…
NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central…
Opinion | Ethics Consult: Prescribe Pills for Pilot’s Peak Performance? MD/JD…
Welcome to Ethics Consult -- an opportunity to discuss, debate (respectfully), and learn…